alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.01



CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



I, Steve Swift, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of WellQuest Medical & Wellness Corporation on Form 10-Q for the fiscal quarter ended March 31, 2009 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of WellQuest Medical & Wellness Corporation.



By:
        
        /s/    STEVE SWIFTDate: May 12, 2009
        
        Name:
        
        Steve SwiftTitle:
        
        ChiefExecutiveOfficer


I, Greg Primm, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of WellQuest Medical & Wellness Corporation on Form 10-Q for the fiscal quarter ended March 31, 2009 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of WellQuest Medical & Wellness Corporation.



By:
        
        /s/    GREG PRIMMDate: May 12, 2009
        
        Name:
        
        Greg PrimmTitle:
        
        Chief Financial Officer




---
Page 1 of 1

IN THE UNITED STATES DISTRICT COURT FOR THE

NORTHERN DISTRICT OF FLORIDA

PENSACOLA DIVISION

EUGENE LONG,

Plaintiff,

vs. Case No. 3:10cv428/LAC/EMT

SGT. STOKES and

OFFICER JACORBS,

Defendants.

___________________________________/

O R D E R

This cause comes on for consideration upon the magistrate judge’s Report and

Recommendation dated November 19, 2010 (Doc. 10). Plaintiff has been furnished a copy of the

Report and Recommendation and has been afforded an opportunity to file objections pursuant to

Title 28, United States Code, Section 636(b)(1). I have made a de novo determination of the

objections filed.

Having considered the Report and Recommendation, and the timely filed objections thereto,

I have determined that the Report and Recommendation should be adopted.

Accordingly, it is now ORDERED as follows:

1. The magistrate judge’s Report and Recommendation is adopted and incorporated by

reference in this order.

2. This action is DISMISSED WITHOUT PREJUDICE as malicious, pursuant to 28

U.S.C. § 1915(e)(2)(B)(i).

3. Any pending motions are DENIED as moot.

DONE AND ORDERED this 3 day of December, 2010. rd

s/L.A. Collier 

LACEY A. COLLIER

SENIOR UNITED STATES DISTRICT JUDGE
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Nursing Research Initial Review Group.                    

*Date:*                         March 5-6, 2007.                    

*Time:*                         8:15 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Crowne Plaza Hotel, 8777 Georgia Avenue, Silver Spring, MD 20910.                    

*Contact Person:*                         Jeffrey M. Chernak, PhD, Scientific Review Administrator, Office of Review, National Institute of Nursing Research, 6701 Democracy Plaza, Suite 710, MSC 4870, Bethesda, MD 20892, (301) 402-6959,                         *chernak@nih.gov*.                     

(Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS)

Dated: January 8, 2007.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 07-98  Filed 1-11-07; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 10.15


 





ASSIGNMENT


 


 





	ASSIGNOR:	Paul I. Bulat
	 	 	 
	ASSIGNEE:	American Doctors On-Line, Inc.
	 	 	200 Myles Standish Blvd.
	 	 	Tauton, Massachusetts 02780
	 	 	 
	STATE OF INCORPORATION OF ASSIGNEE:
	 	 	 
	INVENTION: 	System and Method for Delivering Medical Examination, 
	 	 	Treatment and Assistance Over a Network 
	 	 	 
	ATTORNEY DOCKET:	2551/102
	 	 	 
	SERIAL NO:	10/694,519
	 	 	 
	FILED:	 	October 27, 2003







 


 


Assignor is the sole
inventor (if only one inventor is listed above) or a joint inventor (if more than one inventor is listed above) of the above invention
(the "Invention") described in a United States patent application (the "Application") bearing the above attorney
docket number and having as a title the above name for the Invention. The Application has a Patent and Trademark Office filing
date and serial number as indicated above, or if no filing date and serial number are shown, has a Declaration executed by Assignor
contemporaneously with this Assignment.


 


For valuable
consideration, receipt of which is acknowledged, each Assignor hereby assigns to Assignee (which term shall include Assignee's
successors and assigns), all of Assignor's
right, title and interest in the Invention, all improvements therein, the Application and all priority rights arising therefrom,
and any patents, and any reissues and extensions thereof,
which issue in any country upon any patent applications which correspond with any of the following: the Application, any divisional,
continuation-in-whole, or substitute United States application which is based on the Application; or any continuation-in-part
United States application (including divisions, continuations-in-whole or -in-part, and substitutions thereof or therefor) based
in-part on any of the above described applications.


 


Each Assignor
further agrees that such Assignor and Assignor's heirs
and legal representatives will, without further consideration, cooperate with Assignee in the prosecution of all of the above applications,
execute, verify, acknowledge and deliver all such further papers, including applications for patents and for reissues and extensions
therefor, and instruments of assignment and transfer thereof, and will communicate any facts known to Assignor relating to the
Invention, to obtain or maintain or enforce patents for the Invention and improvements therein in any and all countries and to
vest title thereto in Assignee. Each Assignor further agrees that such Assignor will, without further compensation to Assignor
during the term of such Assignor's employment by Assignee and thereafter for reasonable compensation as determined by Assignee,
perform such other acts as may be reasonably required when requested by Assignee, including
attending depositions, preparing and executing declarations and affidavits and testifying as a witness, to obtain or maintain or
enforce patents for the Invention and improvements therein in any and all countries and to vest title thereto in Assignee.
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of LEAF Equipment Finance Fund 4, L.P. (the Company) on Form 10-Q for the quarter ended
March 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Robert K. Moskovitz, Chief Financial Officer of the General Partner of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                   |  |                                                       |  | 
|------------------ |  | ----------------------------------------------------- |  | 
|Date: May 21, 2010 |  | /s/ Robert K. Moskovitz                              
|                   |  | Name: Robert K. Moskovitz                            
|                   |  | Title: Chief Financial Officer of the General Partner
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION
1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of SolarWinds, Inc. for the quarterly period ended June 30, 2008 as filed with the Securities
and Exchange Commission on the date hereof (the Report), Michael S. Bennett, as Principal Executive Officer of SolarWinds, Inc., hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of his knowledge the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of SolarWinds, Inc.



|                    |  |  |  |     |  |                                     
|------------------- |  |  |  | --- |  | ------------------------------------
|Date: July 31, 2009 |  |  |  | By: |  | /s/ Michael S. Bennett              
|                    |  |  |  |     |  | Michael S. Bennett                  
|                    |  |  |  |     |  | Chairman and Chief Executive Officer
|                    |  |  |  |     |  | (Principal Executive Officer)       

In connection with the Quarterly Report on Form 10-Q of SolarWinds, Inc. for the quarterly period
ended June 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), Kevin B. Thompson, as Principal Financial Officer of SolarWinds, Inc., hereby certifies, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,
and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of SolarWinds, Inc.



|                    |  |  |  |     |  |                                                                          
|------------------- |  |  |  | --- |  | -------------------------------------------------------------------------
|Date: July 31, 2009 |  |  |  | By: |  | /s/ Kevin B. Thompson                                                    
|                    |  |  |  |     |  | Kevin B. Thompson                                                        
|                    |  |  |  |     |  | President, Chief Operating Officer, Chief Financial Officer and Treasurer
|                    |  |  |  |     |  | (Principal Financial Officer)
EX-4.3



 Exhibit 4.3 

BILL OF SALE AND ASSIGNMENT 

This Bill of Sale and Assignment (this “Agreement”), is made and entered into as of July 24, 2012 by and among
(i) Boston Scientific Corporation, a Delaware corporation (“Parent”), (ii) Medifocus, Inc., a Canadian corporation (“Buyer”), and (iii) each of the Sellers (as defined herein):

 RECITALS 

WHEREAS, Parent, Buyer and Sellers (as defined in the Asset Purchase Agreement) have entered into that certain Asset Purchase Agreement
dated as of June 25, 2012 (the “Asset Purchase Agreement”) pursuant to which Buyer is purchasing all right, title and interest in and to the Purchased Assets (capitalized terms used herein and not otherwise
defined shall have the meanings assigned to such terms in the Asset Purchase Agreement); and 
 WHEREAS, this Agreement is being
executed and delivered in connection with and as a condition to the Closing of the transactions contemplated by the Asset Purchase Agreement. 

NOW, THEREFORE, in consideration of the foregoing and of the mutual covenants and promises set forth herein, and for good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows: 
 AGREEMENT

 1. Assignment of Purchased Assets. Parent and each Seller hereby assigns to Buyer, in accordance with the terms and
conditions set forth in the Asset Purchase Agreement, all of its right title and interest in and to the Purchased Assets. 
 2. No
Assignment of Excluded Assets. It is hereby expressly agreed that Parent and/or Sellers shall retain, and Buyer shall not acquire, any other assets of Parent, Sellers or their Affiliates. 

3. Effective Date of Agreement. This Agreement, and the rights and obligations of the parties hereunder, shall take effect as of the
Closing. 
 4. General. This Bill of Sale and Assignment shall be subject to the terms and conditions set forth in the Asset Purchase
Agreement and nothing contained in this Bill of Sale and Assignment shall be construed to limit, terminate or expand the representations, warranties or covenants set forth in the Agreement. 

[The remainder of this page is intentionally left blank.] 







 IN WITNESS WHEREOF, Buyer, Parent and each of Sellers has caused this Bill of Sale and Assignment
to be executed and delivered by an officer thereunto duly authorized on the date first above written. 
  

			
	BOSTON SCIENTIFIC CORPORATION
		
	By:	 	 /s/ Thomas G. Robinson

	Thomas G. Robinson
	Vice President, Strategy and Business Development
	Urology and Women’s Health
	
	BOSTON SCIENTIFIC LIMITED
		
	By:	 	 /s/ Vance R. Brown

	Vance R. Brown
	Vice President and Secretary
	
	BOSTON SCIENTIFIC SCIMED, INC.
		
	By:	 	 /s/ Vance R. Brown

	Vance R. Brown
	Vice President and Secretary
	
	MEDIFOCUS, INC.
		
	By:	 	 /s/ Augustine Y. Cheung

	Augustine Y. Cheung, Ph.D.
	Chief Executive Officer


 [Signature Page to Bill of Sale and Assignment]
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE  CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM
     THE FINANCIAL STATEMENTS OF VOICENET,  INC. AS OF 12/31/99 AND FOR THE
     YEAR THEN ENDED AND IS  QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
     STATEMENTS.
</LEGEND>
<CIK>                         0001023745
<NAME>                        VOICENET, INC.
<MULTIPLIER>                                         1
<CURRENCY>                                         US$

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>               DEC-31-1999
<PERIOD-START>                  JAN-1-1999
<PERIOD-END>                    DEC-31-1999
<EXCHANGE-RATE>                                      1
<CASH>                                       2,916,531
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,916,531
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               6,834,422
<CURRENT-LIABILITIES>                          186,753
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        98,310
<OTHER-SE>                                   6,549,359
<TOTAL-LIABILITY-AND-EQUITY>                 6,834,422
<SALES>                                              0
<TOTAL-REVENUES>                                 3,400
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             1,100,456
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                             (1,053,236)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (1,053,236)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (1,053,236)
<EPS-BASIC>                                      (0.14)
<EPS-DILUTED>                                    (0.14)


</TABLE>
[Federal Register Volume 72, Number 37 (Monday, February 26, 2007)]
[Notices]
[Page 8381]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-884]


=======================================================================
-----------------------------------------------------------------------

EQUAL EMPLOYMENT OPPORTUNITY COMMISSION


 Sunshine Act Meeting

Agency Holding the meeting: Equal Employment Opportunity Commission.

Date and Time: Monday, March 5, 2007, 10 a.m. Eastern Time.

Place: Clarence M. Mitchell, Jr. Conference Room on the Ninth Floor of 
the EEOC Office Building, 1801 ``L'' Street, NW., Washington, DC 20507.

Status: The meeting will be closed to the public.

Matters to be Considered: 

Closed Session: Litigation Recommendation: General Counsel 
Recommendation.


    Note: In accordance with the Sunshine Act, the meeting will be 
open to public observation of the Commission's deliberations and 
voting. (In addition to publishing notices on EEOC Commission 
meetings in the Federal Register, the Commission also provides a 
recorded announcement a full week in advance on future Commission 
sessions.)


    Please telephone (202) 663-7100 (voice) and (202) 663-4074 (TTY) at 
any time for information on these meetings. The EEOC provides sign 
language interpretation at Commission meetings for the hearing 
impaired. Requests for other reasonable accommodations may be made by 
using the voice and TTY numbers listed above.

Contact Person for More Information:
    Stephen Llewellyn, Acting Executive Officer, on (202) 663-4070.

    Dated: February 22, 2007.
Stephen Llewellyn,
Acting Executive Officer, Executive Secretariat.
[FR Doc. 07-884 Filed 2-22-07; 1:30 pm]
BILLING CODE 6570-06-M
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 12-6029

MICHAEL CUNNINGHAM,

Petitioner - Appellant,

v.

ANTHONY PADULA,

Respondent - Appellee.

Appeal from the United States District Court for the District of 

South Carolina, at Anderson. Margaret B. Seymour, District 

Judge. (8:10-cv-01027-MBS)

Submitted: May 17, 2012 Decided: May 24, 2012

Before GREGORY, SHEDD, and DUNCAN, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Michael Cunningham, Appellant Pro Se. Donald John Zelenka, 

Deputy Assistant Attorney General, Columbia, South Carolina, for 

Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Michael Cunningham seeks to appeal the district 

court’s order accepting the recommendation of the magistrate 

judge and denying relief on his 28 U.S.C. § 2254 (2006) petition

and the court’s order denying his Fed. R. Civ. P. 59(e) motion 

to alter or amend that judgment. These orders are not 

appealable unless a circuit justice or judge issues a 

certificate of appealability. See 28 U.S.C. § 2253(c)(1)(A)

(2006); Reid v. Angelone, 369 F.3d 363, 369 (4th Cir. 2004). A 

certificate of appealability will not issue absent “a 

substantial showing of the denial of a constitutional right.” 

28 U.S.C. § 2253(c)(2) (2006). When the district court denies 

relief on the merits, a prisoner satisfies this standard by 

demonstrating that reasonable jurists would find that the 

district court’s assessment of the constitutional claims is 

debatable or wrong. Slack v. McDaniel, 529 U.S. 473, 484 

(2000); see Miller-El v. Cockrell, 537 U.S. 322, 336-38 (2003). 

When the district court denies relief on procedural grounds, the 

prisoner must demonstrate both that the dispositive procedural 

ruling is debatable, and that the petition states a debatable 

claim of the denial of a constitutional right. Slack, 529 U.S. 

at 484-85. 

We have independently reviewed the record and conclude 

that Cunningham has not made the requisite showing. 
3

Accordingly, we deny a certificate of appealability and dismiss 

the appeal. We dispense with oral argument because the facts 

and legal contentions are adequately presented in the materials 

before the court and argument would not aid the decisional 

process.

DISMISSED
Page 1 of 1

IN THE UNITED STATES DISTRICT COURT FOR THE

NORTHERN DISTRICT OF FLORIDA

GAINESVILLE DIVISION

WELLS FARGO BANK NA, 

Plaintiff,

v. CASE NO. 1:11-cv-00127-MP-GRJ

BBMJ. LLC, et al.,

Defendants.

_____________________________/

O R D E R

This matter is before the Court on the parties’ Joint Motion for Extension of

Deadlines. (Doc. 38). The parties move the Court for an extension of deadlines for

their Rule 26(a) disclosures and Rule 26(f) report to February 10, 2012. A motion for

more definite statement is pending before the Court and plaintiff has informed

defendants that it intends to seek leave to amend its complaint to include fraudulent

conveyance claims against one or more defendants.

Accordingly, it is now ORDERED as follows:

1. The parties joint motion for extension of deadlines is GRANTED.

2. The parties shall submit their Rule 26(f) report and make all Rule 26(a)

disclosures on or before February 10, 2012.

DONE AND ORDERED this 26th day of January, 2012. 

áBZtÜç eA ]ÉÇxá 

GARY R. JONES

United States Magistrate Judge

Case 1:11-cv-00127-MP-GRJ Document 39 Filed 01/26/12 Page 1 of 1